IDT Biologika

IDT Biologika is a company that provides CDMO (Contract Development and Manufacturing Organization) services. Their offerings include vaccines, cell and gene therapy, and sterile injectables. They also provide development services such as cell lines, process development, and analytical development, as well as manufacturing services including drug substance production, aseptic filling and lyophilization, packaging, quality control, and regulatory support.

• 2022.03.01

  Reported2022.03.01

  IDT Biologika and Exothera collaborate on viral vaccine manufacturing[2]IDT Biologika与Exothera合作开发病毒疫苗制造工艺prnewswire.com

  IDT Biologika and Exothera announced a collaboration to develop a large-scale manufacturing process for viral vector-based vaccines, using Modified Vaccinia Ankara virus as the first example in a feasibility study.

• 2021.02.11

  Reported2021.02.11

  AstraZeneca and IDT Biologika form vaccine manufacturing partnership[3]阿斯利康与IDT Biologika建立疫苗生产合作pmlive.com

  AstraZeneca and IDT Biologika formed a manufacturing partnership to increase production of AstraZeneca's COVID-19 vaccine in the EU. They intend to jointly invest in additional drug-substance capacity and plan investments at IDT's Dessau site.

Read more

1. 1Home - IDT Biologikaidt-biologika.de
2. 2IDT Biologika与Exothera合作开发病毒疫苗制造工艺prnewswire.com
3. 3阿斯利康与IDT Biologika建立疫苗生产合作pmlive.com